RVL Pharmaceuticals plc Research and Development in Process
RVL Pharmaceuticals plc reported Research and Development in Process of $16.37 million for the 12-month period ending 2017-12-31, per its 8-K filed 2019-12-20.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2019-12-20
| Period end | Research and Development in Process 12 month |
|---|---|
| 2017-12-31 | $16.37M 8-K · filed 2019-12-20 |